Catalyst Wire Dossier Catalyst Wire Dossier

Autologous P63+ Lung Progenitor Cell Transplant

autologous P63+ lung progenitor cell therapy · Ruijin Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous P63+ Lung Progenitor Cell Transplant, covering 2024-10-09 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis [NA]

See pricing